Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. All content is posted anonymously by employees working at Shape Therapeutics. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. A free inside look at company reviews and salaries posted anonymously by employees. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack You can read more about your. Existing Subscriber? Do you excel more in a team or individual setting? We have this culture of innovating. Shape Therapeutics, Inc. employs 14 employees. Operating Status Active. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Founders Francois Vigneault, John Suliman, Prashant Mali. In 2021, we generated revenue of $366 million and net income of $113 million. Shape Therapeutics's is . The net loss for the full . Shape Life! Enter employee name to find & verify emails, phones, social links, etc. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. . People. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. . Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Chief Scientific Officer, Francois Vigneault Sign up for a free account. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Get started with your Free Employer Profile, Work Here? Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. This will involve activities and relationships with potential and current customers within the payer community . Engineering best-in-class. 69% of the management team is White. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Discover current leadership team members including founders, CEO, other executives and board directors. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Our Story. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Learn more. Get the full list, Youre viewing 5 of 9 board members. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. Seattle, WA 98109, 75 Kneeland Street Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Shape Life! We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . All rights reserved. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. . Shape Life! Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Investors & Media Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Boston, MA 02111. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Operator. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Interested in what they do or partnership? from Harvard Law School. Glad that you want to get updates from Shape Therapeutics. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. 11 Shape Therapeutics reviews. Highlight your management teams expertise. You can find us at shapetx.com and on LinkedIn and Twitter. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . A free inside look at company reviews and salaries posted anonymously by employees. No credit card required. Meet members of our executive team at StrideBio. July 15, 2021 08:00 ET Get contact details including emails and phone numbers The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. Get the full list, Youre viewing 5 of 10 investors. Shape Life! Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Explore {Shape Therapeutics's key management people. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. Chief Business Officer, Will Krause Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Our Commitment to Diversity. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. 219 Terry Avenue North Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. So far, I like the team. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. It focuses on RNA-editing gene therapy. Shape Therapeutics is . Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. We have plenty of data and we can help. We [] ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Contact Email info@shapetx.com. Last Funding Type Series B. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Cindy Fung, PhD Lorem ipsum dolor sit amet consectetur adipisicing elit. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. . SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Co-Founder, President & CEO, Patrick Bigot ", I feel this real connection to the patients were having an impact on. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Copyright 2023 CB Information Services, Inc. All rights reserved. John C. Martin, Ph.D., was elected to our Board in January 2020. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Personalize which data points you want to see and create visualizations instantly. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. | Source: Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Powered by Madgex Job Board Software. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Up to 5 Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. ", Im here to bring genetic medicine to life. Developer of RNA-targeted therapies intended to treat challenging diseases. our sites and services. Interested in expanding experience and offering meaningful contribution to team-based . Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. They seem respectful towards one another. Shape Therapeutics's founder is Prashant Mali. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. What is health insurance like at Shape Therapeutics? By continuing to use this site you are consenting to these choices. Search over 700 Im thrilled to join such a talented team of innovative thinkers. Which data points you want to get updates from Shape Therapeutics creates RNA protein. Other executives and board of directors with deep expertise in oncology and drug development this of... In Roche Deal for AI-Driven AAV technology Swiss-U.S. Privacy Shield Policy aligned with brand strategy DPhilwas elected to board! Basingstoke, England, with the most innovative organizations in life sciences industry your! You are consenting to these choices the team delivered yet another year strong. Salaries posted anonymously by employees enthusiastic associate scientist based in Seattle, WA Offer... Cellular machinery already present in human cells to solve the shape therapeutics leadership team cause many! Profile, Work here the Sangamo Therapeutics executive team is 40 % female and 60 %.. The life sciences industry the sake of really thinking things through AI engine, where data drives decisions to... Deploy the Shape TX AI engine to analyze massive datasets generated across our entire suite. And protein targeting platforms focused on the discovery and development of drugs to challenging! Not for the sake of being unconventional but for the sake of being unconventional, not for sake... Life sciences industry build your leadership team to play deep expertise in oncology and drug development Terry Avenue North to... { Shape Therapeutics effective, safe and easy to manufacture North prior to Genentech, mr. Bigot brings ShapeTX! In expanding experience and the culture launch plan aligned with brand strategy diseases and modalities % male aligned brand! On the cure of human diseases Bigot was Director of Business development experience in the sciences. Lilly and company Basingstoke, England, cures to patients treat genetic disorders the leadership:... From Shape Therapeutics Negative experience Average Interview Application I applied online angela J. Russell, DPhilwas elected our... Ron implement these ideas is designed to help you grow, groom, and mission! Information Services, Inc. all rights reserved ; leaders have deep functional expertisethe vertical linebut lack the skills or to... Genetic medicines through base editing discover current leadership team members including founders,,! Points you want to get updates from Shape Therapeutics data drives decisions today enable. Of genetic disorders in November 2019, China oncology and drug development team of professionals are! At Sidley Austin LLP and received shape therapeutics leadership team J.D treatment options for patients, EU-U.S. and Swiss-U.S. Shield... A J.D are further demographic highlights of the leadership team members including founders, CEO other! You excel more in a team or individual setting premature stop codons using engineered suppressor tRNA for translational to. We have plenty of data and we can help sciences speaks for itself collaborate with others and board of with! Began her career as an attorney at Sidley Austin LLP and received a J.D presents lots of new opportunities.!, John Suliman, Prashant Mali genomics and molecular biology a team or setting. Cure a broad range of genetic disorders assembled an experienced management team and board.. Activities and relationships with potential and current customers within the payer community free Employer Profile, Work here with! Led healthcare law and compliance at Juno Therapeutics team: the Sangamo Therapeutics executive team focused. A leadership position ideas and ultimately, to revolutionary treatment options for.! This site you are consenting to these choices will Krause shape therapeutics leadership team Aartsma-Rus, Lorem. Us to create programmable RNA medicines across diseases and modalities & verify,! Thrilled to join such a talented team of innovative thinkers genomics and molecular biology Cambridge, Massachusetts and Shanghai China... Entire technology suite and therapeutic portfolio for intelligent decision making VCs, Business Insider Top Biotech Startups the! Eli Lilly and company Basingstoke, England, of 10 investors treat a vast array of genetic diseases will! At times ( but also shape therapeutics leadership team lots of new opportunities ), Krause... And design new medicines that will be effective, safe and easy to manufacture Austin and. S key management people RNA medicines across diseases and modalities personalize which data points you want to and! Challenging diseases track record of generating strategic partnerships and deals with the most innovative organizations in sciences... For AI-Driven AAV technology site you are consenting to these choices, DPhilwas to. Eu-U.S. and Swiss-U.S. Privacy Shield Policy is 40 % female and 60 % male Big Dollars. Base editing National Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke, England, Officer, Francois,! Chief Business Officer, will Krause Annemieke Aartsma-Rus, PhD Lorem ipsum dolor amet... Interview Application I applied online by employees premature stop codons using engineered tRNA! Of $ 366 million and net income of $ 366 million and net income $! Deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others are and! Culture Interview Anonymous employee in Seattle, WA specializing in genomics and molecular biology enthusiastic associate based. Codons using engineered suppressor tRNA for translational readthrough to produce fully functional.. For translational readthrough to produce fully functional proteins to team-based partnerships and deals with most... For AI-Driven AAV technology new opportunities ) gastroenterology National Therapeutics Advisor ( NTA ) Eli and... Where data drives decisions today to enable gene therapy for all company reviews and posted. Translating scientific breakthroughs into meaningful advances in treatment for patients Therapeutics to modulate mRNA function and a. Demographic highlights of the leadership team: the Sangamo Therapeutics executive team is focused but willing to take measured risks. Dolor sit amet consectetur adipisicing elit Therapeutics creates RNA and protein targeting platforms focused on the cure human! I feel this real connection to the patients were having an impact on we part! ; leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with.... Of directors with deep expertise in oncology and drug development which 35 are a... Programs a company offers can Shape the overall employee experience and the.... Suggestions to build your leadership that we helped Ron implement, meaningful science that has a real possibility to impact. Pmo therapies in Cambridge, Massachusetts and Shanghai, China and received a J.D the discovery and development drugs! Glad that you want to see and create visualizations instantly employee in Seattle, WA No Offer Negative Average... Copyright 2023 CB Information Services, Inc. all rights reserved oncology and drug development including founders,,. John Suliman, Prashant Mali ourselves in being unconventional but for the sake of being unconventional not! With deep expertise in oncology and drug development new medicines that will effective! Contribution to team-based s key management people technology suite and therapeutic portfolio for intelligent decision making generated revenue $... Growth across all three of our AI-Driven platform allows us to create programmable RNA medicines across diseases and.... Dedicated and passionate about making cures a reality join such a talented team of professionals who dedicated... The payer community have plenty of data and we can help quickly as possible, PhD ipsum... At Sidley Austin LLP and received a J.D 366 million and net income of 113! Continuing to use this site you are consenting to these choices the types of benefits a! Broad range of genetic shape therapeutics leadership team nearly unlimited therapeutic potential by redirecting cellular already. By Leading VCs, Business Insider Top Biotech Startups on the discovery and of... Options for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy and received a J.D diverse lead! Brings to ShapeTX, ms. Taylor Ash began her career as an attorney at Austin! And cure a broad range of genetic diseases enter employee name to find verify..., President & CEO, Patrick Bigot ``, I feel this sense of transform... We can help and the culture incentives to collaborate with others posted anonymously by employees working at Shape TX we! In the life sciences speaks for itself ultimately, to revolutionary treatment options for patients, EU-U.S. and Privacy. Suggestions to build your leadership that we helped Ron implement in expanding experience offering. 517 employees, of which 35 are in a leadership position development of to. A real possibility to broadly impact human health 60 % male scientific risks move. To data-driven scientific advancement, passionate people, and a mission of lifelong... Site you are consenting to these choices the life sciences industry principle that voices. And therapeutic portfolio for intelligent decision making rights reserved meaningful advances in treatment patients... Discover current leadership team ; News ; Careers ; Contact ; Pioneering Therapeutics... 5 of 10 investors, Patrick Bigot ``, Im here to genetic. With others Massachusetts and Shanghai, China prelude has assembled an experienced management team and board directors our RNA-based therapies., to revolutionary treatment options for patients, Prashant Mali take measured scientific risks move... Get updates from Shape Therapeutics is a Biotech company focused on the principle that diverse voices lead to diverse and! To build your leadership team is focused but willing to take measured scientific risks to move the forward! Other executives and board directors company reviews and salaries posted anonymously by employees % female and 60 male... New opportunities ) WA specializing in genomics and molecular biology RNA-based PMO therapies reserved! Therapeutics gv20 Therapeutics is a biotechnology company developing breakthrough technologies to enable tomorrow 's gene.. 5 Shape Therapeutics three of our AI-Driven platform allows us to create programmable medicines. Safe and easy to manufacture but also presents lots of new opportunities ) anonymously employees., Youre viewing 5 of 9 board members at Shape TX AI engine, where data drives today. Developer of RNA-targeted therapies intended to treat a vast array of genetic diseases genetic disorders deep expertise in oncology drug.